Haemonetics (HAE) said Monday it has appointed Frank Chan as executive vice president, chief operating officer, from April 7.
Chan most recently was the president of acute care and monitoring at Medtronic (MDT), the firm said.
The medical technology company said it also appointed Roy Galvin as executive vice president, chief commercial officer, effective immediately. Galvin joined Haemonetics in 2022 as president of global plasma and blood center.